MAPK14 and pulmonary fibrosis: We previously found that stem cell therapy inhibited neutrophil migration by downregulating p38 activity on circulating neutrophils in mice with LPS-induced ALI [16], and that nintedanib reduced neutrophil chemotaxis to regulate the severity of bleomycin-induced pulmonary fibrosis [8].